Sales & Marketing Update
Filed with ASX · · 4 pages · English
Resonance Health Ltd (ASX: RHT) (“Resonance Health” or “Company”) has recently been through a period of management transition with several executives appointed. The recruitment of a global salesforce led by an experienced medical sales and marketing executive commenced with the appointment of a GM-Global Sales & Marketing (ASX release, 7 July 2021) and has accelerated, as outlined below. Technolog
Story so far
Earlier from Resonance Health
- New AI Medical Device
- Appointment of GM - Global Sales & Marketing
- Appointment of Managing Director
- Resignation of CEO & Management Changes
- Filing of Patent Application
Later from Resonance Health
- Thalassaemia International Federation to Deploy FerriSmart
- ASO R&D Project - Filing of Two Patent Applications
- Investor Presentation - Positioning for Growth
- LiverSmart Submitted to FDA for US Regulatory Clearance
- ASO Project New Data
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health